Second Genome

Developer of microbiome-based personalized medicine for a wide range of human health disorders

placeSan Francisco, California, United States calendar_todayFounded 2009 groups37 employees language secondgenome.com

Registered entities

Investor mix

15 investors on record; lead investors include SR One, Advanced Technology Ventures, Morgenthaler, Wavepoint Ventures.

Investor typeCountShare
Venture capital1173%
Private equity17%
Other / undisclosed320%
Coming soon